Easing vaccine supply chain tops Jaishankar’s agenda during US visit
Live MintIndian foreign minister S Jaishankar has arrived in the US on a five-day visit that is expected to have the securing of ingredients for vaccine manufacturing in India high on the agenda. India’s two-pronged strategy to beat the current second wave of covid-19 rests on ramping up inoculations across age groups as well as implementing targeted lockdowns. The Jaishankar-Blinken talks could also cover plans for Johnson and Johnson to manufacture its vaccine in India as per an understanding reached during the first Quad Leaders’ summit in March. Jaishankar’s meetings in Washington come against the backdrop of US President Joe Biden saying last week that the country will begin shipping 20 million doses of Pfizer-BioNTech, Moderna and Johnson and Johnson's covid-vaccines to needy countries by June-end.